CHJ-01

N/A

Report date: 2022/01/10 10:59:53
NME

Base Information

Drug NameCHJ-01
Drug Alias NameCHJ-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase 1 inhibitors
TargetsSphingosine kinase 1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong First Medical University
China Registration ClassN/A

Develop Information

Active CompaniesShandong First Medical University
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A